Interregional differences in the clinical,biological and electrical characteristics of first acute coronary events in France: results from the MONICA registries
Restricted accessResearch articleFirst published online April, 2013
Interregional differences in the clinical,biological and electrical characteristics of first acute coronary events in France: results from the MONICA registries
Background: In France, there is a large north-to-south, decreasing gradient in case fatality rates of hospitalized patients for an acute coronary event. This gradient may be explained by differences in the presenting patients’ clinical, biological and electrocardiographic characteristics.
Goal: To compare the characteristics of patients hospitalized for an acute episode of coronary insufficiency in three regions of France with contrasting fatality rates.
Methods: We assessed all men and women (aged 35–74 years) covered by the MONICA registries in three geographical areas (north, east and south-west France) and hospitalized in 2006 for a first acute coronary event. The symptoms, electrocardiogram features, left ventricular ejection fraction (LVEF) and troponin levels were systematically transcribed from medical files. Vital status was followed up for one year.
Results: Fatality rates at 28 days and 1 year were higher in the north (7% and 12%, respectively) than in the east (5% and 7%) and in the south-west (2% and 5%). Major symptoms (such as cardiac arrest, acute pulmonary oedema and cardiac shock), altered LVEF and ST+ myocardial infarction (STEMI) were more frequent in the north than in the south-west (all p < 0.0001) – pointing to marked inter-regional differences in the presentation of acute coronary syndromes (ACSs). In multivariate analyses, age, major symptoms, altered LVEF and STEMI remained strongly associated with 28-day lethality, whereas the relationship with geographical area was attenuated. Similar results were observed for 1-year outcomes.
Conclusions: The clinical, biological and electrocardiographic presentations of hospitalized incident ACSs differ from one region of France to another. These differences explain (at least in part) the 28-day and 1-year decreasing case fatality gradient in hospitalized patients from northern France to south-western France.
MONICA Monograph and multimedia sourcebook. World's largest study of heart disease, stroke, risk factors and population trends, Geneva: WHO, 2003, pp. 1979–2002.
2.
Tunstall-PedoeHKuulasmaaKAmouyelP. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation1994; 90: 583–612.
3.
MontayeMDucimetierePRuidavetsJB. Le gradient Nord-Sud de la morbidité et de la mortalité coronaires en France: données récentes des registres français des cardiopathies ischémiques. Bull Epidemiol Hebdo2006; 8–9: 62–64.
4.
ArveilerDWagnerADucimetiereP. Trends in coronary heart disease in France during the second half of the 1990s. Eur J Cardiovasc Prev Rehabil2005; 12: 209–215.
5.
DucimetierePHaasBRuidavetsJB. Fréquence et mortalité à 28 jours des divers épisodes d'insuffisance coronaire aiguë dans trois régions françaises en 2006. Bull Epidemiol Hebdo2011; 40–41: 419–422.
6.
CottelDDallongevilleJWagnerA. The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol.2000; 16: 317–322.
7.
HowardGCushmanMPrineasRJ. Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med2009; 49: 129–132.
8.
FoxKAGoodmanSBigonziF. Inter-regional differences and outcome in unstable angina; analysis of the international ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events. Eur Heart J2000; 21: 1433–1439.
9.
L'état de santé de la population en France; Rapport 2009–2010. Suivi des objectifs annexés à la loi de santé publique. Direction de la recherche, des études, de l'évaluation et des statistiques, 2011.
10.
GerwardSTydenPHansenO. Survival rate 28 days after hospital admission with first myocardial infarction. Inverse relationship with socio-economic circumstances. J Intern.Med2006; 259: 164–172.
11.
RosengrenAWallentinLSimoonsM. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J2006; 27: 789–795.
12.
WagnerASadounADallongevilleJ. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens2011; 29: 43–50.
13.
TilloyECottelDRuidavetsJB. Characteristics of current smokers, former smokers, and second-hand exposure and evolution between 1985 and 2007. Eur J Cardiovasc Prev Rehabil2010; 17: 730–736.
14.
OhmanEMArmstrongPWChristensonRH. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl.J Med1996; 335: 1333–1341.
15.
KnightCJKeebleTRWilsonS. Short term prognosis of patients with acute coronary syndromes: the level of cardiac troponin T elevation corresponding to the “old” WHO definition of myocardial infarction. Heart2005; 91: 373–374.
16.
Garcia-GarciaCSubiranaISalaJ. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures. Am J Cardiol2011; 108: 1061–1067.
17.
RuidavetsJBMontayeMBinghamA. Prise en charge thérapeutique de l'insuffisance coronaire aiguë inaugurale dans trois régions françaises en 2006. Bull Epidemiol Hebdo2011; 40–41: 426–431.
